VectorBuilder Biotechnology (Guangzhou) Co., Ltd. (hereinafter referred to as VectorBuilder), a top gene delivery enterprise, recently announced the completion of…
Browsing: Legend Capital
GalaxySpace, a Chinese commercial aerospace company, recently completed its latest financing round with a post-investment valuation of approximately RMB11 billion.…
Leadrive Technology, a leading supplier of power semiconductor and motor control solutions for new energy vehicles, recently announced its completion…
Legend Capital recently announced that it made its 100th IPO following the listing of its AI medical portfolio company Lunit…
Shanghai Applied Protein Technology Co., Ltd. (APTBIO), a leading enterprise focused on mass spectrometry-based multi-omics applied to precision medicine, recently…
On August 2, 2022, R&G Pharmastudies Co., Ltd. (SHE: 301333), a China-leading CRO enterprise invested by Legend Capital, was successfully…
On August 5, 2022, Legend Capital portfolio company MicuRx Pharmaceuticals, a scarce enterprise in super antibiotic, was successfully listed on…
Shenzhen Ruicycle Environmental Protection Technology Co., Ltd (also known as Hengchuang Ruineng), a battery recycling company, recently accomplished the B…
Shenzhen AKA Robotics Technology Co., LTD. (hereinafter referred to as AKA Robotics), a leading intelligent special robot company, recently completed…
On July 21st, 2022, Lunit, a leading global AI-based cancer solutions provider invested by Legend Capital, was successfully listed on…
Jiangsu Huili Biotechnology Co., Ltd (Huili Bio), a next-generation synthetic biology enzyme computational design platform, recently announced the completion of…
Legend Capital’s portfolio company Talent New Energy, a new Chinese powerhouse in the solid-state battery industry, recently announced the completion…
On June 14, two of Legend Capital’s portfolio companies, Innovent Biologics, Inc. (Innovent) and PT Etana Biotechnologies Indonesia (Etana), jointly…
On June 8th 2022, Legend Capital’s portfolio company ANYCOLOR, a leading Virtual YouTuber (VTuber) management company in Japan, was listed…
On April 26, 2022, the expedition ship Xuelong 2 for China’s 38th Antarctic expedition berthed at the Shanghai base dock.…
Legend Capital’s portfolio company Xbiome Inc., an industry-leading and AI-driven microbiome therapeutics company, recently announced that it acquired the clinical-stage…
Legend Capital’s portfolio company Lunit, a Korean Medical AI company, recently announced a preliminary approval from the Korea Exchange for…
Shanghai Langsheng Biotechnology Co., Ltd., a subsidiary of Legend Capital’s co-founded company Innostellar Biotherapeutics, announced that the clinical trial application…
On 31 March 2022, Legend Capital’s portfolio company Jiangsu Recbio Technology Co., Ltd. (Recbio, HKG: 2179), a leading novel vaccines…
On 28 February 2022, Inceptio Technology, an autonomous driving truck technology and operation company, announced its completion of a US$188…